img

Global Candesartan and Hydrochlorothiazide Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Candesartan and Hydrochlorothiazide Market Insights, Forecast to 2034

Candesartan and Hydrochlorothiazide contains 2 medicationscandesartan and hydrochlorothiazide. Candesartan belongs to a family of medications known as angiotensin II receptor blockers. Hydrochlorothiazide belongs to a family of medications known as diuretics (or "water pills"). This combination medication is used to lower high blood pressure.
Global Candesartan and Hydrochlorothiazide market is expected to reach to US$ 324 million in 2024, with a positive growth of %, compared with US$ 303 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Candesartan and Hydrochlorothiazide industry is evaluated to reach US$ 470.1 million in 2029. The CAGR will be 6.4% during 2024 to 2029.
Globally, Candesartan and Hydrochlorothiazide key manufacturers include AstraZeneca, ANI Pharmaceuticals, TEVA, Mylan, Dr. Reddy's Laboratories, Zydus Pharmaceuticals, Prinston Pharmaceutical and MACLEODS, etc. AstraZeneca, ANI Pharmaceuticals, TEVA are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Candesartan and Hydrochlorothiazide were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Candesartan and Hydrochlorothiazide market and estimated to attract more attentions from industry insiders and investors.
Candesartan and Hydrochlorothiazide can be divided into 16/12.5, 32/12.5 and 32/25,, etc. 16/12.5 is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Candesartan and Hydrochlorothiazide is widely used in various fields, such as Adults and Geriatric, etc. Adults provides greatest supports to the Candesartan and Hydrochlorothiazide industry development. In 2022, global % sales of Candesartan and Hydrochlorothiazide went into Adults filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Candesartan and Hydrochlorothiazide market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Candesartan and Hydrochlorothiazide market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


AstraZeneca
ANI Pharmaceuticals
TEVA
Mylan
Dr. Reddy's Laboratories
Zydus Pharmaceuticals
Prinston Pharmaceutical
MACLEODS
Segment by Type
16/12.5
32/12.5
32/25

Segment by Application


Adults
Geriatric

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Candesartan and Hydrochlorothiazide plant distribution, commercial date of Candesartan and Hydrochlorothiazide, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Candesartan and Hydrochlorothiazide introduction, etc. Candesartan and Hydrochlorothiazide Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Candesartan and Hydrochlorothiazide
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Candesartan and Hydrochlorothiazide Product Introduction
1.2 Market by Type
1.2.1 Global Candesartan and Hydrochlorothiazide Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 16/12.5
1.2.3 32/12.5
1.2.4 32/25
1.3 Market by Application
1.3.1 Global Candesartan and Hydrochlorothiazide Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Adults
1.3.3 Geriatric
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Candesartan and Hydrochlorothiazide Sales Estimates and Forecasts 2018-2029
2.2 Global Candesartan and Hydrochlorothiazide Revenue by Region
2.2.1 Global Candesartan and Hydrochlorothiazide Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Candesartan and Hydrochlorothiazide Revenue by Region (2018-2024)
2.2.3 Global Candesartan and Hydrochlorothiazide Revenue by Region (2024-2029)
2.2.4 Global Candesartan and Hydrochlorothiazide Revenue Market Share by Region (2018-2029)
2.3 Global Candesartan and Hydrochlorothiazide Sales Estimates and Forecasts 2018-2029
2.4 Global Candesartan and Hydrochlorothiazide Sales by Region
2.4.1 Global Candesartan and Hydrochlorothiazide Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Candesartan and Hydrochlorothiazide Sales by Region (2018-2024)
2.4.3 Global Candesartan and Hydrochlorothiazide Sales by Region (2024-2029)
2.4.4 Global Candesartan and Hydrochlorothiazide Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Candesartan and Hydrochlorothiazide Sales by Manufacturers
3.1.1 Global Candesartan and Hydrochlorothiazide Sales by Manufacturers (2018-2024)
3.1.2 Global Candesartan and Hydrochlorothiazide Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Candesartan and Hydrochlorothiazide in 2022
3.2 Global Candesartan and Hydrochlorothiazide Revenue by Manufacturers
3.2.1 Global Candesartan and Hydrochlorothiazide Revenue by Manufacturers (2018-2024)
3.2.2 Global Candesartan and Hydrochlorothiazide Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Candesartan and Hydrochlorothiazide Revenue in 2022
3.3 Global Key Players of Candesartan and Hydrochlorothiazide, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Candesartan and Hydrochlorothiazide Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Candesartan and Hydrochlorothiazide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Candesartan and Hydrochlorothiazide, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Candesartan and Hydrochlorothiazide, Product Offered and Application
3.8 Global Key Manufacturers of Candesartan and Hydrochlorothiazide, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Candesartan and Hydrochlorothiazide Sales by Type
4.1.1 Global Candesartan and Hydrochlorothiazide Historical Sales by Type (2018-2024)
4.1.2 Global Candesartan and Hydrochlorothiazide Forecasted Sales by Type (2024-2029)
4.1.3 Global Candesartan and Hydrochlorothiazide Sales Market Share by Type (2018-2029)
4.2 Global Candesartan and Hydrochlorothiazide Revenue by Type
4.2.1 Global Candesartan and Hydrochlorothiazide Historical Revenue by Type (2018-2024)
4.2.2 Global Candesartan and Hydrochlorothiazide Forecasted Revenue by Type (2024-2029)
4.2.3 Global Candesartan and Hydrochlorothiazide Revenue Market Share by Type (2018-2029)
4.3 Global Candesartan and Hydrochlorothiazide Price by Type
4.3.1 Global Candesartan and Hydrochlorothiazide Price by Type (2018-2024)
4.3.2 Global Candesartan and Hydrochlorothiazide Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Candesartan and Hydrochlorothiazide Sales by Application
5.1.1 Global Candesartan and Hydrochlorothiazide Historical Sales by Application (2018-2024)
5.1.2 Global Candesartan and Hydrochlorothiazide Forecasted Sales by Application (2024-2029)
5.1.3 Global Candesartan and Hydrochlorothiazide Sales Market Share by Application (2018-2029)
5.2 Global Candesartan and Hydrochlorothiazide Revenue by Application
5.2.1 Global Candesartan and Hydrochlorothiazide Historical Revenue by Application (2018-2024)
5.2.2 Global Candesartan and Hydrochlorothiazide Forecasted Revenue by Application (2024-2029)
5.2.3 Global Candesartan and Hydrochlorothiazide Revenue Market Share by Application (2018-2029)
5.3 Global Candesartan and Hydrochlorothiazide Price by Application
5.3.1 Global Candesartan and Hydrochlorothiazide Price by Application (2018-2024)
5.3.2 Global Candesartan and Hydrochlorothiazide Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Candesartan and Hydrochlorothiazide Market Size by Type
6.1.1 US & Canada Candesartan and Hydrochlorothiazide Sales by Type (2018-2029)
6.1.2 US & Canada Candesartan and Hydrochlorothiazide Revenue by Type (2018-2029)
6.2 US & Canada Candesartan and Hydrochlorothiazide Market Size by Application
6.2.1 US & Canada Candesartan and Hydrochlorothiazide Sales by Application (2018-2029)
6.2.2 US & Canada Candesartan and Hydrochlorothiazide Revenue by Application (2018-2029)
6.3 US & Canada Candesartan and Hydrochlorothiazide Market Size by Country
6.3.1 US & Canada Candesartan and Hydrochlorothiazide Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Candesartan and Hydrochlorothiazide Sales by Country (2018-2029)
6.3.3 US & Canada Candesartan and Hydrochlorothiazide Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Candesartan and Hydrochlorothiazide Market Size by Type
7.1.1 Europe Candesartan and Hydrochlorothiazide Sales by Type (2018-2029)
7.1.2 Europe Candesartan and Hydrochlorothiazide Revenue by Type (2018-2029)
7.2 Europe Candesartan and Hydrochlorothiazide Market Size by Application
7.2.1 Europe Candesartan and Hydrochlorothiazide Sales by Application (2018-2029)
7.2.2 Europe Candesartan and Hydrochlorothiazide Revenue by Application (2018-2029)
7.3 Europe Candesartan and Hydrochlorothiazide Market Size by Country
7.3.1 Europe Candesartan and Hydrochlorothiazide Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Candesartan and Hydrochlorothiazide Sales by Country (2018-2029)
7.3.3 Europe Candesartan and Hydrochlorothiazide Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Candesartan and Hydrochlorothiazide Market Size
8.1.1 China Candesartan and Hydrochlorothiazide Sales (2018-2029)
8.1.2 China Candesartan and Hydrochlorothiazide Revenue (2018-2029)
8.2 China Candesartan and Hydrochlorothiazide Market Size by Application
8.2.1 China Candesartan and Hydrochlorothiazide Sales by Application (2018-2029)
8.2.2 China Candesartan and Hydrochlorothiazide Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Candesartan and Hydrochlorothiazide Market Size by Type
9.1.1 Asia Candesartan and Hydrochlorothiazide Sales by Type (2018-2029)
9.1.2 Asia Candesartan and Hydrochlorothiazide Revenue by Type (2018-2029)
9.2 Asia Candesartan and Hydrochlorothiazide Market Size by Application
9.2.1 Asia Candesartan and Hydrochlorothiazide Sales by Application (2018-2029)
9.2.2 Asia Candesartan and Hydrochlorothiazide Revenue by Application (2018-2029)
9.3 Asia Candesartan and Hydrochlorothiazide Sales by Region
9.3.1 Asia Candesartan and Hydrochlorothiazide Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Candesartan and Hydrochlorothiazide Revenue by Region (2018-2029)
9.3.3 Asia Candesartan and Hydrochlorothiazide Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Candesartan and Hydrochlorothiazide Market Size by Type
10.1.1 Middle East, Africa and Latin America Candesartan and Hydrochlorothiazide Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Candesartan and Hydrochlorothiazide Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Candesartan and Hydrochlorothiazide Market Size by Application
10.2.1 Middle East, Africa and Latin America Candesartan and Hydrochlorothiazide Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Candesartan and Hydrochlorothiazide Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Candesartan and Hydrochlorothiazide Sales by Country
10.3.1 Middle East, Africa and Latin America Candesartan and Hydrochlorothiazide Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Candesartan and Hydrochlorothiazide Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Candesartan and Hydrochlorothiazide Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Information
11.1.2 AstraZeneca Overview
11.1.3 AstraZeneca Candesartan and Hydrochlorothiazide Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 AstraZeneca Candesartan and Hydrochlorothiazide Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AstraZeneca Recent Developments
11.2 ANI Pharmaceuticals
11.2.1 ANI Pharmaceuticals Company Information
11.2.2 ANI Pharmaceuticals Overview
11.2.3 ANI Pharmaceuticals Candesartan and Hydrochlorothiazide Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 ANI Pharmaceuticals Candesartan and Hydrochlorothiazide Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 ANI Pharmaceuticals Recent Developments
11.3 TEVA
11.3.1 TEVA Company Information
11.3.2 TEVA Overview
11.3.3 TEVA Candesartan and Hydrochlorothiazide Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 TEVA Candesartan and Hydrochlorothiazide Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 TEVA Recent Developments
11.4 Mylan
11.4.1 Mylan Company Information
11.4.2 Mylan Overview
11.4.3 Mylan Candesartan and Hydrochlorothiazide Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Mylan Candesartan and Hydrochlorothiazide Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Mylan Recent Developments
11.5 Dr. Reddy's Laboratories
11.5.1 Dr. Reddy's Laboratories Company Information
11.5.2 Dr. Reddy's Laboratories Overview
11.5.3 Dr. Reddy's Laboratories Candesartan and Hydrochlorothiazide Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Dr. Reddy's Laboratories Candesartan and Hydrochlorothiazide Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Dr. Reddy's Laboratories Recent Developments
11.6 Zydus Pharmaceuticals
11.6.1 Zydus Pharmaceuticals Company Information
11.6.2 Zydus Pharmaceuticals Overview
11.6.3 Zydus Pharmaceuticals Candesartan and Hydrochlorothiazide Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Zydus Pharmaceuticals Candesartan and Hydrochlorothiazide Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Zydus Pharmaceuticals Recent Developments
11.7 Prinston Pharmaceutical
11.7.1 Prinston Pharmaceutical Company Information
11.7.2 Prinston Pharmaceutical Overview
11.7.3 Prinston Pharmaceutical Candesartan and Hydrochlorothiazide Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Prinston Pharmaceutical Candesartan and Hydrochlorothiazide Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Prinston Pharmaceutical Recent Developments
11.8 MACLEODS
11.8.1 MACLEODS Company Information
11.8.2 MACLEODS Overview
11.8.3 MACLEODS Candesartan and Hydrochlorothiazide Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 MACLEODS Candesartan and Hydrochlorothiazide Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 MACLEODS Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Candesartan and Hydrochlorothiazide Industry Chain Analysis
12.2 Candesartan and Hydrochlorothiazide Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Candesartan and Hydrochlorothiazide Production Mode & Process
12.4 Candesartan and Hydrochlorothiazide Sales and Marketing
12.4.1 Candesartan and Hydrochlorothiazide Sales Channels
12.4.2 Candesartan and Hydrochlorothiazide Distributors
12.5 Candesartan and Hydrochlorothiazide Customers
13 Market Dynamics
13.1 Candesartan and Hydrochlorothiazide Industry Trends
13.2 Candesartan and Hydrochlorothiazide Market Drivers
13.3 Candesartan and Hydrochlorothiazide Market Challenges
13.4 Candesartan and Hydrochlorothiazide Market Restraints
14 Key Findings in The Global Candesartan and Hydrochlorothiazide Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Candesartan and Hydrochlorothiazide Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of 16/12.5
Table 3. Major Manufacturers of 32/12.5
Table 4. Major Manufacturers of 32/25
Table 5. Global Candesartan and Hydrochlorothiazide Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Candesartan and Hydrochlorothiazide Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Candesartan and Hydrochlorothiazide Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Candesartan and Hydrochlorothiazide Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Candesartan and Hydrochlorothiazide Revenue Market Share by Region (2018-2024)
Table 10. Global Candesartan and Hydrochlorothiazide Revenue Market Share by Region (2024-2029)
Table 11. Global Candesartan and Hydrochlorothiazide Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Candesartan and Hydrochlorothiazide Sales by Region (2018-2024) & (K Units)
Table 13. Global Candesartan and Hydrochlorothiazide Sales by Region (2024-2029) & (K Units)
Table 14. Global Candesartan and Hydrochlorothiazide Sales Market Share by Region (2018-2024)
Table 15. Global Candesartan and Hydrochlorothiazide Sales Market Share by Region (2024-2029)
Table 16. Global Candesartan and Hydrochlorothiazide Sales by Manufacturers (2018-2024) & (K Units)
Table 17. Global Candesartan and Hydrochlorothiazide Sales Share by Manufacturers (2018-2024)
Table 18. Global Candesartan and Hydrochlorothiazide Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Candesartan and Hydrochlorothiazide Revenue Share by Manufacturers (2018-2024)
Table 20. Global Key Players of Candesartan and Hydrochlorothiazide, Industry Ranking, 2021 VS 2022 VS 2024
Table 21. Candesartan and Hydrochlorothiazide Price by Manufacturers 2018-2024 (USD/Unit)
Table 22. Global Candesartan and Hydrochlorothiazide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Candesartan and Hydrochlorothiazide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Candesartan and Hydrochlorothiazide as of 2022)
Table 24. Global Key Manufacturers of Candesartan and Hydrochlorothiazide, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Candesartan and Hydrochlorothiazide, Product Offered and Application
Table 26. Global Key Manufacturers of Candesartan and Hydrochlorothiazide, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Candesartan and Hydrochlorothiazide Sales by Type (2018-2024) & (K Units)
Table 29. Global Candesartan and Hydrochlorothiazide Sales by Type (2024-2029) & (K Units)
Table 30. Global Candesartan and Hydrochlorothiazide Sales Share by Type (2018-2024)
Table 31. Global Candesartan and Hydrochlorothiazide Sales Share by Type (2024-2029)
Table 32. Global Candesartan and Hydrochlorothiazide Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Candesartan and Hydrochlorothiazide Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Candesartan and Hydrochlorothiazide Revenue Share by Type (2018-2024)
Table 35. Global Candesartan and Hydrochlorothiazide Revenue Share by Type (2024-2029)
Table 36. Candesartan and Hydrochlorothiazide Price by Type (2018-2024) & (USD/Unit)
Table 37. Global Candesartan and Hydrochlorothiazide Price Forecast by Type (2024-2029) & (USD/Unit)
Table 38. Global Candesartan and Hydrochlorothiazide Sales by Application (2018-2024) & (K Units)
Table 39. Global Candesartan and Hydrochlorothiazide Sales by Application (2024-2029) & (K Units)
Table 40. Global Candesartan and Hydrochlorothiazide Sales Share by Application (2018-2024)
Table 41. Global Candesartan and Hydrochlorothiazide Sales Share by Application (2024-2029)
Table 42. Global Candesartan and Hydrochlorothiazide Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Candesartan and Hydrochlorothiazide Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Candesartan and Hydrochlorothiazide Revenue Share by Application (2018-2024)
Table 45. Global Candesartan and Hydrochlorothiazide Revenue Share by Application (2024-2029)
Table 46. Candesartan and Hydrochlorothiazide Price by Application (2018-2024) & (USD/Unit)
Table 47. Global Candesartan and Hydrochlorothiazide Price Forecast by Application (2024-2029) & (USD/Unit)
Table 48. US & Canada Candesartan and Hydrochlorothiazide Sales by Type (2018-2024) & (K Units)
Table 49. US & Canada Candesartan and Hydrochlorothiazide Sales by Type (2024-2029) & (K Units)
Table 50. US & Canada Candesartan and Hydrochlorothiazide Revenue by Type (2018-2024) & (US$ Million)
Table 51. US & Canada Candesartan and Hydrochlorothiazide Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Candesartan and Hydrochlorothiazide Sales by Application (2018-2024) & (K Units)
Table 53. US & Canada Candesartan and Hydrochlorothiazide Sales by Application (2024-2029) & (K Units)
Table 54. US & Canada Candesartan and Hydrochlorothiazide Revenue by Application (2018-2024) & (US$ Million)
Table 55. US & Canada Candesartan and Hydrochlorothiazide Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Candesartan and Hydrochlorothiazide Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Candesartan and Hydrochlorothiazide Revenue by Country (2018-2024) & (US$ Million)
Table 58. US & Canada Candesartan and Hydrochlorothiazide Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Candesartan and Hydrochlorothiazide Sales by Country (2018-2024) & (K Units)
Table 60. US & Canada Candesartan and Hydrochlorothiazide Sales by Country (2024-2029) & (K Units)
Table 61. Europe Candesartan and Hydrochlorothiazide Sales by Type (2018-2024) & (K Units)
Table 62. Europe Candesartan and Hydrochlorothiazide Sales by Type (2024-2029) & (K Units)
Table 63. Europe Candesartan and Hydrochlorothiazide Revenue by Type (2018-2024) & (US$ Million)
Table 64. Europe Candesartan and Hydrochlorothiazide Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Candesartan and Hydrochlorothiazide Sales by Application (2018-2024) & (K Units)
Table 66. Europe Candesartan and Hydrochlorothiazide Sales by Application (2024-2029) & (K Units)
Table 67. Europe Candesartan and Hydrochlorothiazide Revenue by Application (2018-2024) & (US$ Million)
Table 68. Europe Candesartan and Hydrochlorothiazide Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Candesartan and Hydrochlorothiazide Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Candesartan and Hydrochlorothiazide Revenue by Country (2018-2024) & (US$ Million)
Table 71. Europe Candesartan and Hydrochlorothiazide Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Candesartan and Hydrochlorothiazide Sales by Country (2018-2024) & (K Units)
Table 73. Europe Candesartan and Hydrochlorothiazide Sales by Country (2024-2029) & (K Units)
Table 74. China Candesartan and Hydrochlorothiazide Sales by Type (2018-2024) & (K Units)
Table 75. China Candesartan and Hydrochlorothiazide Sales by Type (2024-2029) & (K Units)
Table 76. China Candesartan and Hydrochlorothiazide Revenue by Type (2018-2024) & (US$ Million)
Table 77. China Candesartan and Hydrochlorothiazide Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Candesartan and Hydrochlorothiazide Sales by Application (2018-2024) & (K Units)
Table 79. China Candesartan and Hydrochlorothiazide Sales by Application (2024-2029) & (K Units)
Table 80. China Candesartan and Hydrochlorothiazide Revenue by Application (2018-2024) & (US$ Million)
Table 81. China Candesartan and Hydrochlorothiazide Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Candesartan and Hydrochlorothiazide Sales by Type (2018-2024) & (K Units)
Table 83. Asia Candesartan and Hydrochlorothiazide Sales by Type (2024-2029) & (K Units)
Table 84. Asia Candesartan and Hydrochlorothiazide Revenue by Type (2018-2024) & (US$ Million)
Table 85. Asia Candesartan and Hydrochlorothiazide Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Candesartan and Hydrochlorothiazide Sales by Application (2018-2024) & (K Units)
Table 87. Asia Candesartan and Hydrochlorothiazide Sales by Application (2024-2029) & (K Units)
Table 88. Asia Candesartan and Hydrochlorothiazide Revenue by Application (2018-2024) & (US$ Million)
Table 89. Asia Candesartan and Hydrochlorothiazide Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Candesartan and Hydrochlorothiazide Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Candesartan and Hydrochlorothiazide Revenue by Region (2018-2024) & (US$ Million)
Table 92. Asia Candesartan and Hydrochlorothiazide Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Candesartan and Hydrochlorothiazide Sales by Region (2018-2024) & (K Units)
Table 94. Asia Candesartan and Hydrochlorothiazide Sales by Region (2024-2029) & (K Units)
Table 95. Middle East, Africa and Latin America Candesartan and Hydrochlorothiazide Sales by Type (2018-2024) & (K Units)
Table 96. Middle East, Africa and Latin America Candesartan and Hydrochlorothiazide Sales by Type (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Candesartan and Hydrochlorothiazide Revenue by Type (2018-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Candesartan and Hydrochlorothiazide Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Candesartan and Hydrochlorothiazide Sales by Application (2018-2024) & (K Units)
Table 100. Middle East, Africa and Latin America Candesartan and Hydrochlorothiazide Sales by Application (2024-2029) & (K Units)
Table 101. Middle East, Africa and Latin America Candesartan and Hydrochlorothiazide Revenue by Application (2018-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Candesartan and Hydrochlorothiazide Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Candesartan and Hydrochlorothiazide Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Candesartan and Hydrochlorothiazide Revenue by Country (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Candesartan and Hydrochlorothiazide Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Candesartan and Hydrochlorothiazide Sales by Country (2018-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Candesartan and Hydrochlorothiazide Sales by Country (2024-2029) & (K Units)
Table 108. AstraZeneca Company Information
Table 109. AstraZeneca Description and Major Businesses
Table 110. AstraZeneca Candesartan and Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 111. AstraZeneca Candesartan and Hydrochlorothiazide Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. AstraZeneca Recent Developments
Table 113. ANI Pharmaceuticals Company Information
Table 114. ANI Pharmaceuticals Description and Major Businesses
Table 115. ANI Pharmaceuticals Candesartan and Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 116. ANI Pharmaceuticals Candesartan and Hydrochlorothiazide Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. ANI Pharmaceuticals Recent Developments
Table 118. TEVA Company Information
Table 119. TEVA Description and Major Businesses
Table 120. TEVA Candesartan and Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 121. TEVA Candesartan and Hydrochlorothiazide Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. TEVA Recent Developments
Table 123. Mylan Company Information
Table 124. Mylan Description and Major Businesses
Table 125. Mylan Candesartan and Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 126. Mylan Candesartan and Hydrochlorothiazide Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Mylan Recent Developments
Table 128. Dr. Reddy's Laboratories Company Information
Table 129. Dr. Reddy's Laboratories Description and Major Businesses
Table 130. Dr. Reddy's Laboratories Candesartan and Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 131. Dr. Reddy's Laboratories Candesartan and Hydrochlorothiazide Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Dr. Reddy's Laboratories Recent Developments
Table 133. Zydus Pharmaceuticals Company Information
Table 134. Zydus Pharmaceuticals Description and Major Businesses
Table 135. Zydus Pharmaceuticals Candesartan and Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 136. Zydus Pharmaceuticals Candesartan and Hydrochlorothiazide Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Zydus Pharmaceuticals Recent Developments
Table 138. Prinston Pharmaceutical Company Information
Table 139. Prinston Pharmaceutical Description and Major Businesses
Table 140. Prinston Pharmaceutical Candesartan and Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 141. Prinston Pharmaceutical Candesartan and Hydrochlorothiazide Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Prinston Pharmaceutical Recent Developments
Table 143. MACLEODS Company Information
Table 144. MACLEODS Description and Major Businesses
Table 145. MACLEODS Candesartan and Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 146. MACLEODS Candesartan and Hydrochlorothiazide Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. MACLEODS Recent Developments
Table 148. Key Raw Materials Lists
Table 149. Raw Materials Key Suppliers Lists
Table 150. Candesartan and Hydrochlorothiazide Distributors List
Table 151. Candesartan and Hydrochlorothiazide Customers List
Table 152. Candesartan and Hydrochlorothiazide Market Trends
Table 153. Candesartan and Hydrochlorothiazide Market Drivers
Table 154. Candesartan and Hydrochlorothiazide Market Challenges
Table 155. Candesartan and Hydrochlorothiazide Market Restraints
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Candesartan and Hydrochlorothiazide Product Picture
Figure 2. Global Candesartan and Hydrochlorothiazide Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Candesartan and Hydrochlorothiazide Market Share by Type in 2022 & 2029
Figure 4. 16/12.5 Product Picture
Figure 5. 32/12.5 Product Picture
Figure 6. 32/25 Product Picture
Figure 7. Global Candesartan and Hydrochlorothiazide Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Candesartan and Hydrochlorothiazide Market Share by Application in 2022 & 2029
Figure 9. Adults
Figure 10. Geriatric
Figure 11. Candesartan and Hydrochlorothiazide Report Years Considered
Figure 12. Global Candesartan and Hydrochlorothiazide Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Candesartan and Hydrochlorothiazide Revenue 2018-2029 (US$ Million)
Figure 14. Global Candesartan and Hydrochlorothiazide Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Candesartan and Hydrochlorothiazide Revenue Market Share by Region (2018-2029)
Figure 16. Global Candesartan and Hydrochlorothiazide Sales 2018-2029 ((K Units)
Figure 17. Global Candesartan and Hydrochlorothiazide Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Candesartan and Hydrochlorothiazide Sales YoY (2018-2029) & (K Units)
Figure 19. US & Canada Candesartan and Hydrochlorothiazide Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Candesartan and Hydrochlorothiazide Sales YoY (2018-2029) & (K Units)
Figure 21. Europe Candesartan and Hydrochlorothiazide Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Candesartan and Hydrochlorothiazide Sales YoY (2018-2029) & (K Units)
Figure 23. China Candesartan and Hydrochlorothiazide Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Candesartan and Hydrochlorothiazide Sales YoY (2018-2029) & (K Units)
Figure 25. Asia (excluding China) Candesartan and Hydrochlorothiazide Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Candesartan and Hydrochlorothiazide Sales YoY (2018-2029) & (K Units)
Figure 27. Middle East, Africa and Latin America Candesartan and Hydrochlorothiazide Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Candesartan and Hydrochlorothiazide Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Candesartan and Hydrochlorothiazide in the World: Market Share by Candesartan and Hydrochlorothiazide Revenue in 2022
Figure 30. Global Candesartan and Hydrochlorothiazide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Candesartan and Hydrochlorothiazide Sales Market Share by Type (2018-2029)
Figure 32. Global Candesartan and Hydrochlorothiazide Revenue Market Share by Type (2018-2029)
Figure 33. Global Candesartan and Hydrochlorothiazide Sales Market Share by Application (2018-2029)
Figure 34. Global Candesartan and Hydrochlorothiazide Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Candesartan and Hydrochlorothiazide Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Candesartan and Hydrochlorothiazide Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Candesartan and Hydrochlorothiazide Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Candesartan and Hydrochlorothiazide Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Candesartan and Hydrochlorothiazide Revenue Share by Country (2018-2029)
Figure 40. US & Canada Candesartan and Hydrochlorothiazide Sales Share by Country (2018-2029)
Figure 41. U.S. Candesartan and Hydrochlorothiazide Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Candesartan and Hydrochlorothiazide Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Candesartan and Hydrochlorothiazide Sales Market Share by Type (2018-2029)
Figure 44. Europe Candesartan and Hydrochlorothiazide Revenue Market Share by Type (2018-2029)
Figure 45. Europe Candesartan and Hydrochlorothiazide Sales Market Share by Application (2018-2029)
Figure 46. Europe Candesartan and Hydrochlorothiazide Revenue Market Share by Application (2018-2029)
Figure 47. Europe Candesartan and Hydrochlorothiazide Revenue Share by Country (2018-2029)
Figure 48. Europe Candesartan and Hydrochlorothiazide Sales Share by Country (2018-2029)
Figure 49. Germany Candesartan and Hydrochlorothiazide Revenue (2018-2029) & (US$ Million)
Figure 50. France Candesartan and Hydrochlorothiazide Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Candesartan and Hydrochlorothiazide Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Candesartan and Hydrochlorothiazide Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Candesartan and Hydrochlorothiazide Revenue (2018-2029) & (US$ Million)
Figure 54. China Candesartan and Hydrochlorothiazide Sales Market Share by Type (2018-2029)
Figure 55. China Candesartan and Hydrochlorothiazide Revenue Market Share by Type (2018-2029)
Figure 56. China Candesartan and Hydrochlorothiazide Sales Market Share by Application (2018-2029)
Figure 57. China Candesartan and Hydrochlorothiazide Revenue Market Share by Application (2018-2029)
Figure 58. Asia Candesartan and Hydrochlorothiazide Sales Market Share by Type (2018-2029)
Figure 59. Asia Candesartan and Hydrochlorothiazide Revenue Market Share by Type (2018-2029)
Figure 60. Asia Candesartan and Hydrochlorothiazide Sales Market Share by Application (2018-2029)
Figure 61. Asia Candesartan and Hydrochlorothiazide Revenue Market Share by Application (2018-2029)
Figure 62. Asia Candesartan and Hydrochlorothiazide Revenue Share by Region (2018-2029)
Figure 63. Asia Candesartan and Hydrochlorothiazide Sales Share by Region (2018-2029)
Figure 64. Japan Candesartan and Hydrochlorothiazide Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Candesartan and Hydrochlorothiazide Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Candesartan and Hydrochlorothiazide Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Candesartan and Hydrochlorothiazide Revenue (2018-2029) & (US$ Million)
Figure 68. India Candesartan and Hydrochlorothiazide Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Candesartan and Hydrochlorothiazide Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Candesartan and Hydrochlorothiazide Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Candesartan and Hydrochlorothiazide Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Candesartan and Hydrochlorothiazide Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Candesartan and Hydrochlorothiazide Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Candesartan and Hydrochlorothiazide Sales Share by Country (2018-2029)
Figure 75. Brazil Candesartan and Hydrochlorothiazide Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Candesartan and Hydrochlorothiazide Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Candesartan and Hydrochlorothiazide Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Candesartan and Hydrochlorothiazide Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Candesartan and Hydrochlorothiazide Revenue (2018-2029) & (US$ Million)
Figure 80. Candesartan and Hydrochlorothiazide Value Chain
Figure 81. Candesartan and Hydrochlorothiazide Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries